Shoshan-Barmatz V, Hadad N, Feng W, Shafir I, Orr I, Varsanyi M, Heilmeyer L M
Department of Life Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
FEBS Lett. 1996 May 20;386(2-3):205-10. doi: 10.1016/0014-5793(96)00442-5.
In this study we demonstrate the existence of a protein with properties of the voltage-dependent anion channel (VDAC) in the sarcoplasmic reticulum (SR) using multiple approaches as summarized in the following: (a) 35 and 30 kDa proteins in different SR preparations, purified from other membranal systems by Ca2+/oxalate loading and sedimentation through 55% sucrose, cross-react with four different VDAC monoclonal antibodies. (b) Amino acid sequences of three peptides derived from the SR 35 kDa protein are identical to the sequences present in VDAC1 isoform. (c) Similar to the mitochondrial VDAC, the SR protein is specifically labeled by [14C]DCCD. (d) Using a new method, a 35 kDa protein has been purified from SR and mitochondria with a higher yield for the SR. (e) Upon reconstitution into a planar lipid bilayer, the purified SR protein shows voltage-dependent channel activity with properties similar to those of the purified mitochondrial VDAC or VDAC1/porin 31HL from human B lymphocytes, and its channel activity is completely inhibited by the anion transport inhibitor DIDS and about 80% by DCCD. We also demonstrate the translocation of ATP into the SR lumen and the phosphorylation of the luminal protein sarcalumenin by this ATP. Both ATP translocation and sarcalumenin phosphorylation are inhibited by DIDS, but not by atractyloside, a blocker of the ATP/ADP exchanger. These results indicate the existence of VDAC, thought to be located exclusively in mitochondria, in the SR of skeletal muscle, and its possible involvement in ATP transport. Together with recent studies on VDAC multicompartment location and its dynamic association with enzymes and channels, our findings suggest that VDAC deserves attention and consideration as a protein contributing to various cellular functions.
在本研究中,我们采用多种方法证明了肌浆网(SR)中存在一种具有电压依赖性阴离子通道(VDAC)特性的蛋白质,总结如下:(a)通过Ca2+/草酸盐加载和55%蔗糖沉降从其他膜系统中纯化得到的不同SR制剂中的35 kDa和30 kDa蛋白质,与四种不同的VDAC单克隆抗体发生交叉反应。(b)源自SR 35 kDa蛋白质的三个肽段的氨基酸序列与VDAC1同工型中的序列相同。(c)与线粒体VDAC类似,SR蛋白被[14C]DCCD特异性标记。(d)使用一种新方法,已从SR和线粒体中纯化出一种35 kDa的蛋白质,SR的产量更高。(e)在重构到平面脂质双层中后,纯化的SR蛋白表现出电压依赖性通道活性,其特性与纯化的线粒体VDAC或人B淋巴细胞中的VDAC1/孔蛋白31HL相似,并且其通道活性被阴离子转运抑制剂DIDS完全抑制,被DCCD抑制约80%。我们还证明了ATP转运到SR腔中以及该ATP对腔内蛋白肌浆网素的磷酸化作用。ATP转运和肌浆网素磷酸化均被DIDS抑制,但不被ATP/ADP交换体的阻滞剂苍术苷抑制。这些结果表明,被认为仅存在于线粒体中的VDAC存在于骨骼肌的SR中,并且其可能参与ATP转运。连同最近关于VDAC多隔室定位及其与酶和通道的动态关联的研究,我们的发现表明VDAC作为一种对各种细胞功能有贡献的蛋白质值得关注和考虑。